San Diego-based Otonomy, a biopharmaceuticals company developing treatments for disorders of the inner and middle ear, said Thursday that it has added Vickie Capps to its board of directors. Capps was previously EVP, CFO, and treasure for DJO Global, and also previously had served at Ernst & Young. Capps also sits on the board of RF Surgical Systems and Consonance Capital Partners, and had been on the board of SenoRx. Otonomy said Capps will also become chair of its audit committee. Otonomy is venture backed by Aperture Venture Partners, Avalon Ventures, Domain Associates, Novo Ventures, Orbimed Advisors, Osage University Partners, RiverVest Venture Partners, and TPG Ventures.